Clinical Trials

Several clinical trials are currently actively recruiting participants to evaluate interventions and diagnostic methodologies for conditions such as prostate cancer and racism-related life stress. Operating under unassigned or non-applicable phase designations, these studies are sponsored by federal entities like the VA Office of Research and Development as well as major academic institutions, including the Chinese University of Hong Kong, Northwestern University, and Johns Hopkins University. Together, these research endeavors aim to advance diagnostic precision and stress resilience management.

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05422638 Recruiting
Life Stress|Racism
VA Office of Research and Development
2023-01-02 Not Applicable
NCT05295407 Recruiting
Prostate Cancer
NorthShore University HealthSystem|Northwestern University|Johns Hopkins University|GoPath Diagnostics
2021-12-13 --
NCT05438524 Recruiting
Prostate Cancer
Chinese University of Hong Kong
2021-11-11 --

(data from https://clinicaltrials.gov, updated on 2024-05-22)

Check the 2-Phenylimidazole product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Compliance for Clinical Use

Mechanism and Biochemical Profile

2-Phenylimidazole functions by binding transition metal ions and active coordination sites via its nitrogen atoms, thereby blocking downstream biochemical complex formation and disrupting cellular enzymatic activity. This modulation of metallo-protein interactions and cellular function highlights its potential relevance in therapeutic research for conditions such as prostate cancer.

Appendix RUO and cGMP Quality Standards

Quality Dimension RUO (Research Use Only) cGMP (Current Good Manufacturing Practice)
Clinical Applicability Prohibited in human clinical trials or medical diagnostics. Mandatory for human clinical trials (Phase I–III) and therapies.
Regulatory Status Non-regulated grade; exempt from drug manufacturing laws. Legally enforced by health authorities (e.g., FDA, EMA, NMPA).
Facility Environment Unclassified analytical or research laboratories. Validated Cleanrooms (ISO Class 5–8) with continuous monitoring.
Quality Control Basic purity and activity testing. Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma).
Process Validation Basic equipment calibration; no process validation required. Full qualification (IQ/OQ/PQ) and complete batch records.
Quality Assurance Vendor self-declared without required formal QMS. Mandatory QA/QC unit, Change Control, CAPA, and vendor audits.
Regulatory Impact High risk of IND rejection if used as a critical raw material. Required for IND/NDA filings, supported by Drug Master Files (DMF).

Footnotes

Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).

Jump to

Note: Technical data last updated: Sep 1, 2026.